Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benzodiazepines: selective administration.

J Ananth1

  • 1Psychopharmacology Unit, Harbor UCLA Medical Center, Torrance 90509.

Journal of Affective Disorders
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The problems of Indian psychiatrists in an alien culture.

Indian journal of psychiatry·2011
Same author

Clinical aspects of dyskinesia.

Indian journal of psychiatry·2011
Same author

Is Western training relevant to Indian psychiatry?

Indian journal of psychiatry·2011
Same author

Catatonic stupor and temporal lobe epilepsy.

Indian journal of psychiatry·2011
Same author

Three day crisis resolution unit.

Indian journal of psychiatry·2011
Same author

Three day crisis resolution unit.

Indian journal of psychiatry·2011
Same journal

Consensus by design: Conflict of interest and the intravenous ketamine Delphi guidelines.

Journal of affective disorders·2026
Same journal

Impaired crying despite preserved emotional experience under antidepressant treatment: An under-recognized clinical phenomenon.

Journal of affective disorders·2026
Same journal

Corrigendum to "Effects of neuronavigation-guided rTMS on serum BDNF, TrkB and VGF levels in depressive patients with suicidal ideation" [J. Affect. Disord. 323 (2023) 617-623].

Journal of affective disorders·2026
Same journal

Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorder.

Journal of affective disorders·2026
Same journal

Age-varying associations between attitudes toward suicide and suicidal ideation in Chinese psychiatric outpatients.

Journal of affective disorders·2026
Same journal

Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

Journal of affective disorders·2026
See all related articles

Benzodiazepines offer anxiolytic, anticonvulsant, muscle relaxant, and hypnotic effects. Future research aims to develop targeted anxiolytic drugs without side effects like sedation.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Benzodiazepines are a class of psychoactive drugs known for their anxiolytic, anticonvulsant, muscle relaxant, and hypnotic properties.
  • Twelve benzodiazepine preparations are available in the USA, categorized into triazolo, 3-nitro, 3-OH, or 2-keto groups.

Purpose of the Study:

  • To review the properties and classifications of benzodiazepines.
  • To discuss drug interactions involving benzodiazepines.
  • To explore the potential of novel benzodiazepine receptor antagonists for targeted therapeutic applications.

Main Methods:

  • Literature review of benzodiazepine classifications and properties.
  • Analysis of known drug interactions with benzodiazepines.
  • Discussion of emerging benzodiazepine receptor antagonists.

Related Experiment Videos

Main Results:

  • Benzodiazepines exhibit a range of pharmacological actions.
  • Several drug classes interact with benzodiazepines.
  • Benzodiazepine receptor antagonists capable of selectively blocking specific actions have been identified.

Conclusions:

  • Future benzodiazepine therapies may offer anxiolytic effects without sedation or anticonvulsant activity.
  • Guidelines for appropriate drug selection and dependence prevention are crucial.
  • Selective benzodiazepine receptor antagonists represent a promising avenue for developing safer anxiolytic medications.